[Antidepressant medication in children].

Area of Science:

• Child and Adolescent Psychiatry
• Pharmacology
• Clinical Psychology

Background:

• Antidepressant use in children requires careful consideration.
• Psychotherapeutic interventions are generally recommended as first-line treatments.
• Selective Serotonin Reuptake Inhibitors (SSRIs) have varying efficacy for pediatric mental health conditions.

Purpose of the Study:

• To outline the appropriate use of antidepressant medications in children.
• To detail the efficacy and safety considerations of SSRIs in pediatric populations.
• To emphasize the importance of combining medication with psychotherapy.

Main Methods:

• Review of current clinical guidelines and research on pediatric antidepressant use.
• Analysis of SSRI efficacy for depression, Obsessive Compulsive Disorder (OCD), and anxiety disorders in children.
• Examination of safety monitoring protocols for SSRI treatment in young patients.

Main Results:

• SSRIs are not first-line treatments for pediatric depression; psychotherapy is preferred.
• SSRIs demonstrate low to moderate efficacy for depression, but moderate to high efficacy for pediatric OCD and anxiety disorders.
• Fluoxetine is the most studied SSRI, while sertraline and fluvoxamine are approved for OCD.
• Close monitoring for side effects, including suicidal behavior (risk approx. 1 in 100 in the first 4 weeks), is crucial.
• Antidepressant use must be combined with psychotherapy and psychosocial interventions.

Conclusions:

• SSRIs should be used cautiously in children, primarily for OCD and anxiety disorders, and never as a first-line treatment for depression.
• Psychotherapy should always be the initial approach, with SSRIs considered as an adjunct therapy.
• Vigilant monitoring for adverse effects, particularly suicidal ideation, is essential during the initial phase of SSRI treatment in pediatric patients.